How has been the historical performance of UTI AMC?

Answer:The historical performance of UTI AMC shows a consistent growth trend in net sales and profits over the years, with net sales reaching 1,851.09 Cr in March 2025, up from 1,736.96 Cr in March 2024 and significantly higher than 1,266.86 Cr in March 2023. The total operating income mirrored this growth, increasing to 1,851.09 Cr in March 2025 from 1,736.96 Cr in the previous year. Operating profit, excluding other income, also saw a rise to 1,101.57 Cr in March 2025, compared to 1,033.40 Cr in March 2024, while profit before tax increased to 1,052.17 Cr from 986.84 Cr. Profit after tax for March 2025 was reported at 812.96 Cr, slightly up from 802.03 Cr in March 2024. However, consolidated net profit showed a slight decline to 731.49 Cr in March 2025 from 765.68 Cr in March 2024. The company maintained a strong operating profit margin of 59.51% in March 2025, indicating efficient cost management.

In terms of assets and liabilities, total assets rose to 5,658.41 Cr in March 2025 from 5,341.02 Cr in March 2024, while total liabilities also increased to 5,658.41 Cr from 5,341.02 Cr, reflecting a balanced growth. The cash flow from operating activities improved to 536.00 Cr in March 2025, up from 325.00 Cr in March 2024, contributing to a net cash inflow of 105.00 Cr compared to an outflow of 58.00 Cr in the previous year. Overall, UTI AMC's financial performance demonstrates a positive trajectory in revenue and profit generation, alongside effective cash flow management.

Breakdown:
UTI AMC's financial performance has shown significant growth over the years, particularly in net sales, which increased from 1,266.86 Cr in March 2023 to 1,851.09 Cr in March 2025. This upward trend is reflected in total operating income, which reached 1,851.09 Cr in March 2025. Operating profit, excluding other income, also rose to 1,101.57 Cr, indicating improved operational efficiency. Profit before tax increased to 1,052.17 Cr, while profit after tax was reported at 812.96 Cr, demonstrating strong profitability despite a slight decline in consolidated net profit to 731.49 Cr. The company's operating profit margin remained robust at 59.51%. On the balance sheet, total assets grew to 5,658.41 Cr, matching the total liabilities, which also increased, indicating stable financial health. Cash flow from operating activities improved significantly to 536.00 Cr, contributing to a positive net cash inflow of 105.00 Cr, showcasing effective cash management strategies.